DMH to Present at 2017 Value Based Strategies for Reimbursement & Formulary Success
Mary Holloway, President of DMH BioPharm, will be presenting on “Understanding the FDA’s Draft Guidance on Health Care Economic Information Communication with Payors, Formulary Committees and Similar Entities” on November 6, 2017.
http://exlevents.com/vbs-for-reimbursement-and-formulary-success/#